GlassScriptPhysician profile
Marcelo M Ghersi
NPI 1134340565
$4,492.91
in general payments reported to CMS, 2019-2025
12 companies · $605 in 2025
The $605 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $185 · 2021: $713 · 2022: $1,579 · 2023: $569 · 2024: $343 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $2,061.99 | 2019-2022 | |
| Mentor Worldwide LLC | $779.94 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Siltex Round Spectrum |
| Musculoskeletal Transplant Foundation INC. | $664.36 | 2022-2025 | |
| Motiva USA, LLC | $337.64 | 2025 | |
| Stryker Corporation | $171.85 | 2023 | Spy-Phi System |
| Allergan, INC. | $171.77 | 2021-2022 | |
| Abbvie INC. | $128.09 | 2023-2025 | |
| Axogen | $103.60 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.58 | 2024 | Exparel |
| Galderma Laboratories, L.P. | $18.84 | 2023 | |
| Tepha INC | $18.40 | 2019 | |
| Eagle Pharmaceuticals, INC. | $16.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcelo Ghersi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.